LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer
出版年份 2020 全文链接
标题
LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-19
DOI
10.1038/s41598-020-64979-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Investigation of adhesive interactions in the specific targeting of Triptorelin-conjugated PEG-coated magnetite nanoparticles to breast cancer cells
- (2018) Jingjie Hu et al. Acta Biomaterialia
- Adhesion of ligand-conjugated biosynthesized magnetite nanoparticles to triple negative breast cancer cells
- (2017) John D. Obayemi et al. Journal of the Mechanical Behavior of Biomedical Materials
- LHRH-Targeted Drug Delivery Systems for Cancer Therapy
- (2017) Xiaoning Li et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems
- (2017) Janel Kydd et al. Pharmaceutics
- Dual effect of F-actin targeted carrier combined with antimitotic drug on aggressive colorectal cancer cytoskeleton: Allying dissimilar cell cytoskeleton disrupting mechanisms
- (2016) Shahrouz Taranejoo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: Effects of particle size on drug release kinetics and cell viability
- (2016) J.D. Obayemi et al. Materials Science & Engineering C-Materials for Biological Applications
- A conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancer
- (2016) Shengsheng Zhu et al. Scientific Reports
- Drug delivery and release systems for targeted tumor therapy
- (2015) David Böhme et al. JOURNAL OF PEPTIDE SCIENCE
- Biosynthesis and the conjugation of magnetite nanoparticles with luteinizing hormone releasing hormone (LHRH)
- (2015) J.D. Obayemi et al. Materials Science & Engineering C-Materials for Biological Applications
- Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers
- (2015) Alessandro Parodi et al. Nanomedicine
- Bioactive prodigiosin-impregnated cellulose matrix for the removal of pathogenic bacteria from aqueous solution
- (2015) K. V. Arivizhivendhan et al. RSC Advances
- Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125
- (2014) Stephan Seitz et al. BMC CANCER
- Targeted Drug Delivery Systems for Pancreatic Cancer
- (2014) Vaibhav Khare et al. Journal of Biomedical Nanotechnology
- Prodigiosin release from an implantable biomedical device: kinetics of localized cancer drug release
- (2014) Y. Danyuo et al. Materials Science & Engineering C-Materials for Biological Applications
- Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
- (2014) L. M. Zasadil et al. Science Translational Medicine
- AEZS-108: a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors
- (2012) Joerg Engel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Biosynthesis and adhesion of gold nanoparticles for breast cancer detection and treatment
- (2012) E. Hampp et al. JOURNAL OF MATERIALS RESEARCH
- Triple negative breast cancer: unmet medical needs
- (2010) Sumanta Kumar Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- Triple negative breast cancers: Clinical and prognostic implications
- (2009) S.J. Dawson et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now